AP4M1
Chr 7ARadaptor related protein complex 4 subunit mu 1
Also known as: CPSQ3, MU-4, MU-ARP2, SPG50
This protein is a subunit of the AP-4 complex that recognizes and sorts cargo proteins with tyrosine-based motifs from the trans-Golgi network to the endosomal-lysosomal system. Mutations cause spastic paraplegia 50, an autosomal recessive disorder. The pathogenic mechanism involves disrupted intracellular protein trafficking between these membrane compartments.
Definitive — sufficient evidence for diagnostic panels
Population Genetics & Constraint
gnomAD v4 — loss-of-function & missense intolerance
Highly tolerant — LoF variants common in population
Tolerant to missense variation
ClinVar Variant Classifications
500 submitted variants in ClinVar
Classification Summary
Curated Variants Distribution
Classified variants from ClinVar · 5 ACMG categories
| Classification | LoF | Missense + Inframe | Non-coding | Synonymous | Total |
|---|---|---|---|---|---|
Pathogenic | 20 | 1 | 11 | 0 | 32 |
Likely Pathogenic | 24 | 1 | 3 | 0 | 28 |
VUS | 5 | 195 | 17 | 3 | 220 |
Likely Benign | 2 | 3 | 80 | 84 | 169 |
Benign | 0 | 1 | 23 | 1 | 25 |
Conflicting | — | 5 | |||
| Total | 51 | 201 | 134 | 88 | 479 |
LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly
View in ClinVar →Protein Context — Lollipop Plot
AP4M1 · protein map & ClinVar variants
Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.
3D Protein StructureAlphaFold
External Resources
Links to major genomics databases and tools
Clinical Trials
Active and recruiting trials from ClinicalTrials.gov
Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47)
NOT YET RECRUITINGPhase 3 Efficacy Study With Concurrent Control of IT MELPIDA in SPG50.Concurrent Controls.
RECRUITINGMelpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt)
RECRUITINGAdministration of MELPIDA to Determine the Safety and Efficacy for Patients With Spastic Paraplegia Type 50
ACTIVE NOT RECRUITINGExternal Resources
Links to major genomics databases and tools